AIM IMMUNOTECH INC. Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31)
AIM IMMUNOTECH INC. (AIM) reported Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) of $145.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount · last filed 2015-03-19
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2011-12-31 was -$189.00K.
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2010-12-31 was $0.00.
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2014 was $145.00K, a 81.88% decline from fiscal 2013.
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2013 was $800.00K, a 8788.89% increase from fiscal 2012.
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2012 was $9.00K, a 86.96% decline from fiscal 2011.
- AIM IMMUNOTECH INC. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2011 was $69.00K.
| Period end | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 3 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 9 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2014-12-31 | $145.00K 10-K · filed 2015-03-19 | ||
| 2013-12-31 | $800.00K 10-K · filed 2015-03-19 | ||
| 2012-12-31 | $9.00K 10-K · filed 2015-03-19 | ||
| 2011-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $69.00K 10-K · filed 2014-03-14 | |
| 2011-09-30 | $258.00K 10-Q · filed 2012-11-02 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $0.00 10-K · filed 2012-03-14 | |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-09 | ||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |